rs4845374

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000565.4(IL6R):​c.1067-17T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.187 in 1,294,146 control chromosomes in the GnomAD database, including 19,147 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 2621 hom., cov: 31)
Exomes 𝑓: 0.19 ( 16526 hom. )

Consequence

IL6R
NM_000565.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.62

Publications

24 publications found
Variant links:
Genes affected
IL6R (HGNC:6019): (interleukin 6 receptor) This gene encodes a subunit of the interleukin 6 (IL6) receptor complex. Interleukin 6 is a potent pleiotropic cytokine that regulates cell growth and differentiation and plays an important role in the immune response. The IL6 receptor is a protein complex consisting of this protein and interleukin 6 signal transducer (IL6ST/GP130/IL6-beta), a receptor subunit also shared by many other cytokines. Dysregulated production of IL6 and this receptor are implicated in the pathogenesis of many diseases, such as multiple myeloma, autoimmune diseases and prostate cancer. Alternatively spliced transcript variants encoding distinct isoforms have been identified in this gene. A pseudogene of this gene is found on chromosome 9. [provided by RefSeq, Aug 2020]
IL6R Gene-Disease associations (from GenCC):
  • hyper-IgE recurrent infection syndrome 5, autosomal recessive
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 1-154454471-T-A is Benign according to our data. Variant chr1-154454471-T-A is described in ClinVar as Benign. ClinVar VariationId is 1165317.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.244 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL6RNM_000565.4 linkc.1067-17T>A intron_variant Intron 8 of 9 ENST00000368485.8 NP_000556.1 P08887-1A0N0L5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL6RENST00000368485.8 linkc.1067-17T>A intron_variant Intron 8 of 9 1 NM_000565.4 ENSP00000357470.3 P08887-1

Frequencies

GnomAD3 genomes
AF:
0.181
AC:
27232
AN:
150300
Hom.:
2614
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.248
Gnomad AMI
AF:
0.196
Gnomad AMR
AF:
0.124
Gnomad ASJ
AF:
0.186
Gnomad EAS
AF:
0.104
Gnomad SAS
AF:
0.176
Gnomad FIN
AF:
0.153
Gnomad MID
AF:
0.179
Gnomad NFE
AF:
0.164
Gnomad OTH
AF:
0.160
GnomAD2 exomes
AF:
0.189
AC:
36479
AN:
192926
AF XY:
0.188
show subpopulations
Gnomad AFR exome
AF:
0.281
Gnomad AMR exome
AF:
0.114
Gnomad ASJ exome
AF:
0.199
Gnomad EAS exome
AF:
0.137
Gnomad FIN exome
AF:
0.198
Gnomad NFE exome
AF:
0.199
Gnomad OTH exome
AF:
0.192
GnomAD4 exome
AF:
0.188
AC:
215211
AN:
1143738
Hom.:
16526
Cov.:
21
AF XY:
0.186
AC XY:
107445
AN XY:
576474
show subpopulations
African (AFR)
AF:
0.280
AC:
7839
AN:
28028
American (AMR)
AF:
0.105
AC:
3865
AN:
36980
Ashkenazi Jewish (ASJ)
AF:
0.192
AC:
4285
AN:
22336
East Asian (EAS)
AF:
0.119
AC:
4122
AN:
34772
South Asian (SAS)
AF:
0.178
AC:
13043
AN:
73420
European-Finnish (FIN)
AF:
0.178
AC:
8308
AN:
46638
Middle Eastern (MID)
AF:
0.207
AC:
1025
AN:
4952
European-Non Finnish (NFE)
AF:
0.193
AC:
163551
AN:
847970
Other (OTH)
AF:
0.189
AC:
9173
AN:
48642
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
8432
16864
25297
33729
42161
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5700
11400
17100
22800
28500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.181
AC:
27266
AN:
150408
Hom.:
2621
Cov.:
31
AF XY:
0.178
AC XY:
13082
AN XY:
73406
show subpopulations
African (AFR)
AF:
0.248
AC:
10146
AN:
40906
American (AMR)
AF:
0.124
AC:
1873
AN:
15084
Ashkenazi Jewish (ASJ)
AF:
0.186
AC:
643
AN:
3458
East Asian (EAS)
AF:
0.105
AC:
536
AN:
5128
South Asian (SAS)
AF:
0.177
AC:
843
AN:
4768
European-Finnish (FIN)
AF:
0.153
AC:
1578
AN:
10286
Middle Eastern (MID)
AF:
0.169
AC:
49
AN:
290
European-Non Finnish (NFE)
AF:
0.164
AC:
11082
AN:
67500
Other (OTH)
AF:
0.163
AC:
338
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1009
2018
3026
4035
5044
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
294
588
882
1176
1470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.174
Hom.:
287
Bravo
AF:
0.180
Asia WGS
AF:
0.173
AC:
603
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 20% of patients studied by a panel of primary immunodeficiencies. Number of patients: 18. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.30
DANN
Benign
0.84
PhyloP100
-1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4845374; hg19: chr1-154426947; COSMIC: COSV59818794; COSMIC: COSV59818794; API